• Bifendate Inhibits Autophagy and Lipid Accumulation in Hepat

  2026-05-22

  The referenced study demonstrates that bifendate (DDB), a hepatoprotective agent, inhibits multiple steps of the autophagy pathway and reduces oleic acid-induced lipid droplet accumulation in vitro. These findings provide mechanistic insight into DDB's potential therapeutic action in hepatic lipid metabolism, with implications for research on non-alcoholic fatty liver disease.

• Accelerating Neurotherapeutic Discovery: FDA-Approved Librar

  2026-05-21

  Explore how the DiscoveryProbe™ FDA-approved Drug Library transforms drug discovery for neurodevelopmental disorders by enabling mechanistic screens, rapid repositioning, and translational insights. Drawing on recent breakthroughs in MeCP2-TBL1 interaction inhibition, this thought-leadership article offers strategic guidance for researchers aiming to bridge molecular pathology and therapeutic innovation.

• Repurposing Safe Drugs to Direct DNA Repair in CRISPR Editin

  2026-05-21

  This study systematically screened FDA-approved drugs to identify modulators of DNA double-strand break repair pathway choice in human stem cells during CRISPR editing. The findings enable programmable control over genome editing outcomes, supporting advances in disease modeling, gene therapy, and synthetic lethality strategies.

• Safe DNA Gel Stain: Sensitive, Safer DNA and RNA Gel Stainin

  2026-05-20

  Safe DNA Gel Stain offers high-sensitivity nucleic acid detection in agarose and acrylamide gels with reduced mutagenicity. This DNA and RNA gel stain enables visualization with blue-light excitation, lowering DNA damage and improving cloning efficiency compared to ethidium bromide.

• PPT (Propyl Pyrazole Triol): Precision Tools for ERα Signali

  2026-05-20

  PPT (Propyl Pyrazole Triol) empowers researchers with subtype-specific activation of estrogen receptor alpha, enabling rigorous dissection of ERα-mediated pathways in cancer and developmental models. This article delivers an applied, protocol-centric guide with troubleshooting insights grounded in recent biomarker and ceRNA network advances.

• Efficient iPSC Differentiation to Retinal Ganglion Cells via

  2026-05-19

  This study introduces a robust, chemically defined protocol for differentiating induced pluripotent stem cells (iPSCs) into functional retinal ganglion cells (RGCs) by concurrently inhibiting SMAD and Wnt pathways. The method significantly improves yield and reproducibility, addressing critical limitations in RGC generation for glaucoma and neurodegenerative disease research.

• JC-1 Mitochondrial Membrane Potential Assay Kit: Workflows &

  2026-05-19

  Unlock sensitive, reproducible assessment of mitochondrial health with the JC-1 Mitochondrial Membrane Potential Assay Kit. This guide details experimental best practices, advanced immunometabolic workflows, and troubleshooting strategies, drawing on recent research and practical lab experience.

• Brefeldin A (SKU B1400): Reproducible ER Stress & Apoptosis

  2026-05-18

  This article provides a scenario-driven, evidence-based guide for using Brefeldin A (SKU B1400) in cell viability, apoptosis, and protein trafficking assays. By addressing common laboratory challenges and comparing vendor quality, we demonstrate how Brefeldin A from APExBIO supports reproducible, interpretable results for advanced cell biology research.

• Cisplatin (CDDP): Applied Workflows and Troubleshooting in C

  2026-05-18

  Cisplatin (CDDP) remains a benchmark DNA crosslinking agent for apoptosis, tumor inhibition, and chemoresistance studies. This guide translates recent advances—including exosome rescue of granulosa cell apoptosis—into actionable protocols and troubleshooting strategies, empowering researchers to maximize reproducibility and insight.

• Bifendate Inhibits Autophagy and Reduces Lipid Droplet Accum

  2026-05-17

  This study elucidates how bifendate (DDB) disrupts multiple steps of the autophagy process and attenuates oleic acid-induced intracellular lipid droplet accumulation in vitro. The findings establish a mechanistic link between autophagy inhibition and hepatic lipid homeostasis, providing a foundation for future research into metabolic liver disease therapies.

• BGJ398 (NVP-BGJ398): Precision FGFR Inhibition in Translatio

  2026-05-16

  Explore how BGJ398 (NVP-BGJ398), a highly selective FGFR inhibitor, is revolutionizing FGFR-driven malignancies research. This article bridges new mechanistic insights—including developmental biology findings on Fgfr2—with actionable guidance for translational researchers. Gain strategic and practical recommendations for leveraging BGJ398 in experimental workflows, understand its competitive edge, and anticipate the next evolution in FGFR-targeted oncology.

• Safe DNA Gel Stain: Elevating DNA and RNA Gel Visualization

  2026-05-15

  Safe DNA Gel Stain from APExBIO revolutionizes DNA and RNA visualization workflows by offering high sensitivity, blue-light compatibility, and dramatically improved safety over traditional stains. This article details hands-on protocol enhancements, troubleshooting guidance, and the translational impact of adopting this less mutagenic, next-generation nucleic acid stain.

• BRD4 Inhibition Potentiates Erastin-Induced Ferroptosis via

  2026-05-15

  This study demonstrates that BRD4 inhibitors, including I-BET-762, broadly enhance erastin-induced ferroptosis across multiple cancer cell lines by promoting reactive oxygen species (ROS) accumulation and downregulating FSP1. The findings elucidate a mechanistic basis for combining BET inhibition with ferroptosis inducers as a potential anti-cancer strategy.

• CD28-ARS2 Axis Drives Metabolic Flexibility in CD8+ T Cells

  2026-05-14

  This study uncovers a novel CD28-ARS2 signaling axis that orchestrates alternative splicing of pyruvate kinase (PKM) in CD8+ T cells, promoting PKM2 isoform dominance and enhancing metabolic adaptability for antitumor immunity. The findings elucidate a key mechanistic link between T cell costimulation, mRNA splicing, and effector function, offering promising avenues for immunometabolic intervention.

• Safe DNA Gel Stain: Practical Guidance for Nucleic Acid Visu

  2026-05-14

  Safe DNA Gel Stain offers a safer, less mutagenic alternative to ethidium bromide for DNA and RNA visualization in agarose or acrylamide gels. It is optimized for blue-light and UV excitation, reducing DNA damage during imaging. However, it is less effective for detecting low molecular weight DNA bands (100–200 bp) and is not recommended for diagnostic use.

413 records 8/28 page Previous Next First page 上5页 678910 下5页 Last page